Genscript Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	959.53	594.49	560.48	625.7	490.1
Revenue Growth (YoY)	61.40%	6.07%	-10.42%	27.67%	25.39%
Cost of Revenue	406.32	322.36	289.85	321.62	207.58
Gross Profit	553.2	272.13	270.63	304.08	282.52
Selling, General & Admin	228.06	202.5	186.96	350.81	302.48
Research & Development	71.23	53.79	52.7	390.1	358.4
Operating Expenses	297.96	262.84	244.44	742.06	661.81
Operating Income	255.25	9.28	26.19	-437.98	-379.29
Interest Expense	-17.29	-8.03	-5.74	-13.27	-2.38
Interest & Investment Income	26.1	28.89	22.58	13.22	6.55
Earnings From Equity Investments	-320.38	-39.07	-1.38	-	-
Currency Exchange Gain (Loss)	-13.05	1.57	2.54	-	-
Other Non Operating Income (Expenses)	20.55	5.66	5.38	-0.96	-3.52
EBT Excluding Unusual Items	-48.82	-1.71	49.58	-438.98	-378.63
Impairment of Goodwill	-	-	-	-11.48	-
Gain (Loss) on Sale of Investments	-421.72	-123.58	130.97	18.77	-138.73
Asset Writedown	-	-45.51	-11.66	-	-
Pretax Income	-470.53	-170.8	168.89	-431.69	-517.36
Income Tax Expense	61.87	2.98	6.01	-3.72	0.96
Earnings From Continuing Operations	-532.4	-173.77	162.88	-427.97	-518.33
Earnings From Discontinued Operations	-	3,029	-518	-	-
Net Income to Company	-532.4	2,855	-355.12	-427.97	-518.33
Minority Interest in Earnings	-0.43	106.59	259.64	201.12	159.62
Net Income	-532.83	2,962	-95.48	-226.85	-358.71
Net Income to Common	-532.83	2,962	-95.48	-226.85	-358.71
Shares Outstanding (Basic)	2,167	2,121	2,109	2,097	2,031
Shares Outstanding (Diluted)	2,167	2,178	2,109	2,097	2,031
Shares Change (YoY)	-0.50%	3.27%	0.58%	3.28%	6.83%
EPS (Basic)	-0.25	1.40	-0.05	-0.11	-0.18
EPS (Diluted)	-0.25	1.40	-0.05	-0.11	-0.18
Free Cash Flow	241.62	-120.14	-539.36	-336.41	-269.83
Free Cash Flow Per Share	0.11	-0.06	-0.26	-0.16	-0.13
Gross Margin	57.65%	45.77%	48.28%	48.60%	57.65%
Operating Margin	26.60%	1.56%	4.67%	-70.00%	-77.39%
Profit Margin	-55.53%	498.22%	-17.04%	-36.26%	-73.19%
Free Cash Flow Margin	25.18%	-20.21%	-96.23%	-53.76%	-55.06%
EBITDA	318.35	70.04	83.5	-388.9	-341.57
EBITDA Margin	33.18%	11.78%	14.90%	-62.15%	-69.69%
D&A For EBITDA	63.1	60.75	57.3	49.08	37.72
EBIT	255.25	9.28	26.19	-437.98	-379.29
EBIT Margin	26.60%	1.56%	4.67%	-70.00%	-77.39%
Effective Tax Rate	-	-	3.56%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.